Superstring Capital Asset Manager Profile - aVenture Research
Superstring Capital is a New York City-based venture capital firm focusing on late-stage investments in the biotech and pharmaceutical sectors. The firm typically participates in Series B and Series C funding rounds, with investments ranging from $50 million to $170 million.
Notable portfolio companies include AffaMed Therapeutics, ReCode Therapeutics, and Shoreline Biosciences. Superstring Capital's investment strategy appears to target companies developing innovative therapeutics and biotechnologies. The firm likely provides strategic guidance and industry connections to support its portfolio companies' growth and development in the competitive life sciences sector.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
